fingolimod hydrochloride has been researched along with sesquiterpenes in 2 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (sesquiterpenes) | Trials (sesquiterpenes) | Recent Studies (post-2010) (sesquiterpenes) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 17,489 | 536 | 7,668 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, P; Chai, S; Liu, J; Sun, S; Wang, Y; Wu, K; Xiao, X; Yan, H; Yang, C; Yuan, Y; Zhang, J; Zhao, M | 1 |
| Asif, M; Khalid, SH; Khan, IU; Khaniabadi, PM; Oon, CE; Saadullah, M; Saleem, M; Yaseen, HS; Yehya, AH; Zubair, HM | 1 |
2 other study(ies) available for fingolimod hydrochloride and sesquiterpenes
| Article | Year |
|---|---|
Curcumol and FTY720 synergistically induce apoptosis and differentiation in chronic myelomonocytic leukemia via multiple signaling pathways.
Topics: Animals; Apoptosis; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Fingolimod Hydrochloride; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Sesquiterpenes; Signal Transduction | 2021 |
Potential role of marine species-derived bioactive agents in the management of SARS-CoV-2 infection.
Topics: Alkaloids; Anti-Inflammatory Agents; Antiviral Agents; COVID-19 Drug Treatment; Depsipeptides; Fingolimod Hydrochloride; Humans; Lectins; Marine Biology; Molecular Docking Simulation; Oceans and Seas; Peptides, Cyclic; Phycocyanin; Phytochemicals; Plant Lectins; Polyphenols; Polysaccharides; SARS-CoV-2; Seaweed; Sesquiterpenes | 2021 |